IDX-184 is a superior HCV direct-acting antiviral drug: A QSAR study

Citation:
Elfiky, A. A., and W. M. Elshemey, "IDX-184 is a superior HCV direct-acting antiviral drug: A QSAR study", Medicinal Chemistry Research, vol. 25, issue 5, pp. 1005 - 1008, 2016.

Abstract:

n/a

Notes:

Export Date: 14 January 2021

Related External Link

Tourism